Science's 2021 Breakthrough of the Year: AI-Powered Protein Prediction

For nearly 50 years, scientists have struggled to solve one of nature’s most perplexing challenges - predicting the complex 3D shape a string of amino acids will fold into as it becomes a working protein. This year, scientists have shown that artificial intelligence (AI)-driven software can achieve this long-standing goal and predict accurate protein structures by the thousands. To honor this feat, Science has named AI-powered protein prediction as its 2021 breakthrough of the year.

"This is a breakthrough on two fronts," writes Science Editor-in-Chief Holden Thorp in a related Editorial. "First, it solves a scientific problem that has been on the to-do list for 50 years... Second, it's a game-changing technique that, like CRISPR or cryo-EM, will greatly accelerate scientific discovery." Proteins are the building blocks of life and their functions - central to nearly all biological processes - are directly related to their three-dimensional shape. Once, determining a protein’s structure was a time consuming and costly processes, requiring complicated lab analyses. And, while attempts to develop computer models capable of solving the "protein-folding problem" have been ongoing for decades, accurate protein prediction has eluded researchers until two seminal papers, published simultaneously in Nature and Science, presented AlphaFold and RoseTTA-fold, respectively. Both approaches demonstrate the ability to predict a wide variety of complex protein structures quickly and accurately based solely on the amino acids they contain. What’s more, the authors of both groups made their data freely available to researchers, greatly expanding the accessibility of obtaining protein structures.

Runners up for the Breakthrough of the Year include the development of antiviral pills to fight COVID-19, new measurements of the muon, seismic observations from Mars, recovering ancient human DNA from soils, in vivo application of CRISPR, new insights into early human development, use of psychedelic drugs to treat PTSD, development of lab-made monoclonal antibodies for treating infectious disease, and advancements in fusion energy generation.

Thorp HH.
Proteins, proteins everywhere.
Science. 2021 Dec 17;374(6574):1415. doi: 10.1126/science.abn5795

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...